BSE filing, NSE: RFSL. Summary written from the filing by ALFA Finder's alert engine.
Richfield Financial Services Ltd: key numbers
- Share price
- ₹20.80
- Market cap
- ₹20.08 Cr
- Revenue (annual)
- ₹12.20 Cr
- Net profit (annual)
- ₹0.35 Cr
- P/E (TTM)
- 33.8×Sector 20.8×
- Promoter holding
- 37.13%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Richfield Financial Services Ltd
All →Richfield Financial Services Q2 FY27 Results: Net Profit ₹0.1 Cr, Down 66.7% YoY
Richfield Financial Services Ltd reported revenue from operations of ₹4.9 Cr (+81.5% YoY) and net profit of ₹0.1 Cr (-66.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr · -66.7% YoY
Richfield Financial Services Board Meeting Date
Richfield Financial Services will hold a board meeting on 12 November 2026 to consider unaudited standalone half-yearly results for September 2026. Trading window closes from 1 October to 14 November 2026.
Richfield Financial Services Other Announcement
A standard quarterly shareholding pattern filing for Richfield Financial Services Ltd. The document details the company's equity distribution among promoters, public, and non-institutional shareholders.
Richfield Financial Services Management Change
Richfield Financial Services re-appointed its MD Vadasseril Georgekutty and Independent Director Indu Kamala Ravindran. Both take effect 11 October 2026 for a 60-month term.
Richfield Financial Services Debt & Borrowing: ₹1.41 Cr
Richfield Financial Services Ltd allotted 14,110 Secured Redeemable Non-Convertible Debentures (NCDs) on a private placement basis worth Rs. 1.411 Crore.
- Value
- ₹1.41 Cr
Richfield Financial Services Annual General Meeting
Richfield Financial Services Ltd conducted its 34th Annual General Meeting on September 24, 2026. Shareholders approved all agenda items, including financial statements and key re-appointments.
Other management change announcements
All →Novelix Pharmaceuticals Management Change
Novelix Pharmaceuticals redesignated Venkateshwarlu Pulluru from Whole-Time Director to Non-Executive Director from 11 November 2026. He stays on the Board but gives up executive duties.
Tera Software Management Change
Tera Software appointed Mr. G. Venkatanarayana as Chief Financial Officer and KMP effective December 4, 2026, filling the vacancy from Anilkumar's resignation. The CFO change is a senior management appointment.
Prima Industries Management Change
Prima Industries appointed Mr. Kushagra Gupta as Managing Director for five years from 12 November 2026, filling a vacancy after the Chairman and MD's demise. Shareholder approval is still pending.
- Execution
- 5 years from 12 November 2026
V B Desai Financial Services Management Change
V.B. Desai Financial Services disclosed the resignation of non-independent director Rachana Shashank Vijayakar effective November 12, 2026, citing personal commitments. Annexure I and her resignation letter are enclosed.
Dolfin Rubbers Management Change
Dolfin Rubbers Limited disclosed the resignation of Independent Director Yashul Goyal, effective 12 November 2026, citing pre-occupation. The company confirmed no other material reasons for the resignation.
Rashtriya Chemicals & Fertilizers Management Change
Rashtriya Chemicals extended Nazhat Shaikh's tenure as Director (Finance) and CFO until March 31, 2027. Two firms were also appointed as internal auditors.
- Execution
- December 1, 2026 to March 31, 2027, or until further orders, whichever is earlier